COLO-BColoplast A/S
399.30DKK-1.92%Mkt Cap: 89.99B DKKP/E: 42.75Last update: 2026-05-13

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Co…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)42.75
P/E (Forward)15.08
PEG1.15
P/B6.51
P/S3.21
EV/EBITDA9.82
EV/Revenue4.03
EPS (TTM)9.34
EPS (Forward)26.48
Cash Flow & Leverage
FCF Yield8.00%
FCF Margin25.69%
Operating CF2.77B DKK
CapEx (TTM)1.35B DKK
Net Debt/EBITDA2.01
Net Debt23.16B DKK
Technical
SMA 50426.42 (-6.4%)
SMA 200531.41 (-24.9%)
Beta0.50
S&P 52W Chg24.23%
Avg Vol (30d)347.39K
Avg Vol (10d)359.63K
Technical Indicators
RSI (14)39.2
MACD-9.2550
MACD Signal-10.0724
MACD Hist.+0.8174
BB Upper441.60 DKK
BB Middle412.63 DKK
BB Lower383.66 DKK
BB Width14.04%
ATR (14)10.20 DKK
Vol Ratio (20d)0.99x
52W Range
390.103% of range656.80
52W High656.80 DKK
52W Low390.10 DKK
Profitability
Gross Margin67.59%
EBITDA Margin41.07%
Profit Margin18.69%
Oper. Margin25.69%
ROE28.16%
ROA10.51%
Revenue Growth2.20%
Earnings Growth
Balance Sheet
Debt/Equity1.26
Current Ratio1.75
Quick Ratio1.01
Book Value/Sh61.31 DKK
Cash/Share4.739 DKK
Dividends
Fwd Div Rate23.00 DKK
Trail. Div Rate23.00 DKK
Div. Yield5.76%
5Y Avg Yield2.67%
Payout Ratio246.25%
Ex-Div DateMay 18, 2026
Pay Date
Splits
Last Split5:1
Split DateDec 19, 2012
Ownership
Shares Out.207.37M
Float143.38M
Insiders29.79%
Institutions29.78%
Analyst Consensus
Rating3.1 (Hold)
Target (Mean)480.90 DKK
Target Range380.00 DKK760.00 DKK
# Analysts20
Company
Market Cap89.99B DKK
Enterprise Value113.07B DKK
Revenue (TTM)28.05B DKK
Gross Profit18.27B DKK
Net Income (TTM)5.05B DKK
Revenue/Share124.48 DKK
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees17.1K
Last Price399.30 DKK
CountryDK
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS19624Y2000